Sarasin & Partners LLP Purchases 571,131 Shares of Colgate-Palmolive (NYSE:CL)

Sarasin & Partners LLP raised its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 19.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,537,856 shares of the company's stock after purchasing an additional 571,131 shares during the quarter. Colgate-Palmolive accounts for approximately 3.5% of Sarasin & Partners LLP's holdings, making the stock its 12th biggest position. Sarasin & Partners LLP owned about 0.43% of Colgate-Palmolive worth $321,626,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CL. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth about $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $64,000. True Wealth Design LLC lifted its holdings in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC boosted its position in shares of Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after purchasing an additional 368 shares during the period. Institutional investors own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CL. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Stifel Nicolaus lowered their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a research report on Friday. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. Finally, Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and an average target price of $101.11.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL traded up $0.23 during midday trading on Monday, hitting $88.79. 5,149,874 shares of the company traded hands, compared to its average volume of 3,679,883. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm's fifty day moving average is $92.20 and its 200-day moving average is $97.76. The firm has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.